Home List your patent My account Help Support us

TRILAYER TABLET FOR THE TREATMENT OF DIABETES MELLITUS

[Category : - HEALTH]
[Viewed 883 times]

The present invention provides methods for preparing trilayer tablet compositions and
methods for treating diseases and disorders associated with SGLT2 activity using trilayer tablet
compositions.Metformin may be in the form of a pharmaceutically acceptable salt,
where metformin hydrochloride (HCl) is preferred. A preferred SGLT2 inhibitor are
dapagliflozin or a pharmaceutically acceptable salt thereof, dapagliflozin (S) propylene glycol
hydrate (1: 1: 1) or dapagliflozin (R) propylene glycol hydrate (1: 1: 1) and empagliflozin. The
SGLT2 inhibitors composition is an immediate release composition or a sustained release
composition, wherein an immediate release composition is preferred.

Raspbery48 @ gmail.com

Financial information

Indian patent application number : 202011038801
Link to patent Link
Raspbery48 @ gmail.com

Patent publications:

No publication

Asking price:

Above 1 million USD

Rate this patent

Great invention
Liked: 1 times

Viewed: 883 times

Seller:

idivyesh (India)

Ask a question
or start a negotiation

Contact the seller

Share on social media